- Scientists based in Whitechapel will recruit 24 members of the public
- The study will test if a jab developed by Hvivo will successfully fight COVID-19
- Participants will be injected with two weaker strains of the coronavirus
- Some 20 vaccines are in development and the UK government will fund £46m
The Queen Mary BioEnterprises Innovation Centre, London, is recruiting 24 people for the study.
They will be injected with two weaker strains of the deadly virus – which has killed more than 3,800 people worldwide – giving them similar respiratory symptoms.
A jab developed by the company Hvivo will then be tested. Patients will remain in quarantine for two weeks to see if it is successful.
Some 35 other vaccines are in development, and the UK government has promised an extra £46million in the fight against coronavirus.
However, experts have said a vaccine is unlikely to be approved in time to halt the current epidemic, which has so far seen more than 110,00 people across the globe fall ill with COVID-19.
Volunteers can be paid £3,500 to be infected with coronavirus in a study at The Queen Mary BioEnterprises Innovation Centre in Whitechapel
Scientists will recruit 24 members of the public for the study which will involve being infected with two weaker strains of coronavirus, followed by a vaccine developed by the company Hvivo (stock)
The UK government has promised an extra £46million in the fight against coronavirus.